Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 560 participants.

Also called NCT05527717

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 560 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05527717
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05527717. Randomized; no masking; primary purpose treatment. Start 2022-11-16 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
Acronym
RESCUE-SHOCK
Condition
Cardiogenic Shock
Condition
Acute Myocardial Infarction
Condition
Multi Vessel Coronary Artery Disease
Condition
Extracorporeal Membrane Oxygenation
Intervention (Procedure)
Culprit lesion only PCI (percutaneous coronary intervention)
Intervention (Procedure)
Immediate multi-vessel PCI
Lead sponsor
Samsung Medical Center (class: other)

Record details

Record id
cardio:ct-nct05527717
Content hash
2651de94830306ab4a8e04e1159a438fc7d10fc0c2c75318e293864a3e42539d